IVF
INVO Fertility, Inc.
Overview
INVO Fertility, Inc is a Healthcare company operating in Medical Devices with a $2.5M market cap.
Most recent reported earnings: Q1 FY2026 (Jun 15, 2026).
10 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q2 FY2023Earnings2023-08-145 Q&A exchanges
- Q1 FY2023Earnings2023-05-159 Q&A exchanges
- Q4 FY2022Earnings2023-04-1711 Q&A exchanges
- Q3 FY2022Earnings2022-11-1411 Q&A exchanges
- Q2 FY2022Earnings2022-08-1528 Q&A exchanges
- Q1 FY2022Earnings2022-05-1614 Q&A exchanges
- Q4 FY2021Earnings2022-03-3116 Q&A exchanges
- Q3 FY2021Earnings2021-11-1520 Q&A exchanges
- Q2 FY2021Earnings2021-08-1728 Q&A exchanges
- Q1 FY2021Earnings2021-05-1821 Q&A exchanges
History
Earnings history
- Q1 FY20262026-06-15EPS$-99.99 vs ——Rev$1.6M vs ——EODHD
- Q4 FY20252025-12-30EPS— vs $-22.00—Rev$1.6M vs ——EODHD
- Q3 FY20252025-11-16EPS$-0.77 vs ——Rev$1.8M vs ——EODHD
- Q2 FY20252025-08-13EPS$-8.07 vs ——Rev$1.9M vs ——EODHD
- Q1 FY20252025-04-29EPS$-1084.80 vs $-420.00-100.0%Rev$1.6M vs ——EODHD
- Q4 FY20242024-12-30EPS$-1084.80 vs $-420.00-100.0%Rev$1.7M vs ——EODHD
- Q3 FY20242024-11-10EPS$-604.26 vs ——Rev$1.4M vs ——EODHD
- Q2 FY20242024-08-13EPS$-895.63 vs ——Rev$1.8M vs ——EODHD
- Q1 FY20242024-05-12EPS$-604.70 vs ——Rev$1.6M vs ——EODHD
- Q3 FY20232023-11-12EPS$-0.70 vs $-2.20+68.2%Rev$974.9K vs ——EODHD
- Q2 FY20232023-08-13EPS$-3.06 vs $-3.20+4.4%Rev$315.9K vs ——EODHD
- Q4 FY20222023-04-16EPS$-0.23 vs $-0.19-21.1%Rev$348.0K vs ——EODHD
- Q3 FY20222022-11-13EPS$-0.21 vs $-0.12-75.0%Rev$235.3K vs ——EODHD
- Q2 FY20222022-08-14EPS$-4.60 vs $-0.24-100.0%Rev$146.1K vs ——EODHD
- Q1 FY20222022-05-15EPS$-4.60 vs $-0.25-100.0%Rev$162.6K vs ——EODHD
- Q4 FY20212022-03-30EPS$0.20 vs $-0.22+100.0%Rev$3.0M vs ——EODHD
- Q3 FY20212021-11-14EPS$-4.80 vs $-0.20-100.0%Rev$218.9K vs ——EODHD
- Q2 FY20212021-08-15EPS$-3.40 vs $-0.19-100.0%Rev$208.5K vs ——EODHD
- Q1 FY20212021-05-16EPS$-5.00 vs $-0.25-100.0%Rev$684.5K vs ——EODHD
- Q4 FY20202021-03-29EPS$-9.50 vs $0.00—Rev$196.6K vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2026 | 2026-06-15 | $-99.99 | — | — | $1.6M | — | — | EODHD |
| Q4 FY2025 | 2025-12-30 | — | $-22.00 | — | $1.6M | — | — | EODHD |
| Q3 FY2025 | 2025-11-16 | $-0.77 | — | — | $1.8M | — | — | EODHD |
| Q2 FY2025 | 2025-08-13 | $-8.07 | — | — | $1.9M | — | — | EODHD |
| Q1 FY2025 | 2025-04-29 | $-1084.80 | $-420.00 | -100.0% | $1.6M | — | — | EODHD |
| Q4 FY2024 | 2024-12-30 | $-1084.80 | $-420.00 | -100.0% | $1.7M | — | — | EODHD |
| Q3 FY2024 | 2024-11-10 | $-604.26 | — | — | $1.4M | — | — | EODHD |
| Q2 FY2024 | 2024-08-13 | $-895.63 | — | — | $1.8M | — | — | EODHD |
| Q1 FY2024 | 2024-05-12 | $-604.70 | — | — | $1.6M | — | — | EODHD |
| Q3 FY2023 | 2023-11-12 | $-0.70 | $-2.20 | +68.2% | $974.9K | — | — | EODHD |
| Q2 FY2023 | 2023-08-13 | $-3.06 | $-3.20 | +4.4% | $315.9K | — | — | EODHD |
| Q4 FY2022 | 2023-04-16 | $-0.23 | $-0.19 | -21.1% | $348.0K | — | — | EODHD |
| Q3 FY2022 | 2022-11-13 | $-0.21 | $-0.12 | -75.0% | $235.3K | — | — | EODHD |
| Q2 FY2022 | 2022-08-14 | $-4.60 | $-0.24 | -100.0% | $146.1K | — | — | EODHD |
| Q1 FY2022 | 2022-05-15 | $-4.60 | $-0.25 | -100.0% | $162.6K | — | — | EODHD |
| Q4 FY2021 | 2022-03-30 | $0.20 | $-0.22 | +100.0% | $3.0M | — | — | EODHD |
| Q3 FY2021 | 2021-11-14 | $-4.80 | $-0.20 | -100.0% | $218.9K | — | — | EODHD |
| Q2 FY2021 | 2021-08-15 | $-3.40 | $-0.19 | -100.0% | $208.5K | — | — | EODHD |
| Q1 FY2021 | 2021-05-16 | $-5.00 | $-0.25 | -100.0% | $684.5K | — | — | EODHD |
| Q4 FY2020 | 2021-03-29 | $-9.50 | $0.00 | — | $196.6K | — | — | EODHD |
Source: EODHD. IVF reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks IVF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 9/10 quarters with 70% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 3 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2023 | $0.83 | $0.73 | +13.7% | +5.6% | +4.5% |
| Q4 FY2023 | $0.96 | $0.88 | +8.7% | +6.9% | +5.1% |
| Q3 FY2023 | $1.02 | $0.92 | +10.7% | -1.4% | +1.5% |
| Q2 FY2023 | $0.98 | $0.95 | +3.4% | -2.5% | -1.4% |
| Q1 FY2022 | $0.95 | $0.90 | +5.2% | +6.4% | +4.2% |
| Q4 FY2022 | $0.80 | $0.81 | -1.6% | +7.1% | +9.7% |
| Q3 FY2022 | $0.91 | $0.81 | +12.0% | +4.2% | +5.2% |
| Q2 FY2022 | $0.89 | $0.80 | +11.8% | +5.3% | +5.0% |
| Q1 FY2021 | $0.93 | $0.90 | +3.8% | -2.5% | -1.7% |
| Q4 FY2021 | $1.03 | $1.03 | +0.1% | +0.3% | -1.7% |
Guidance change history
Sample- Q1 FY2023Raised2023-04-15
- Q4 FY2023Raised2023-13-15
- Q3 FY2023Raised2023-10-15
- Q2 FY2023Maintained2023-07-15
- Q1 FY2022Raised2022-04-15
- Q4 FY2022Maintained2022-13-15
- Q3 FY2022Raised2022-10-15
- Q2 FY2022Raised2022-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Steve ShumCEO4 yr 8 mo10 callsCurrentSample
CEO since 2021 • 6/8 beats (75%) • last guidance raise Q1 FY2023
- Terah Renee KrigsvoldCFO6 mono recorded callsCurrentSample
CFO since 2025 • 1/2 beats (50%) • guidance suspended Q2 FY2023
- Andrea GorenCFO5 yr9 callsCurrentSample
CFO since 2021 • 4/8 beats (50%) • guidance suspended Q3 FY2023
- Michael Jos CampbellCOO1 yr 4 mono recorded callsFormerSample
COO since 2022 • 2/4 beats (50%) • last guidance cut Q1 FY2023
- Kevin DoodyMedical Director5 mono recorded callsFormerSample
OTHER since 2022 • 3/4 beats (75%) • guidance suspended Q2 FY2023
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for IVF.
$ curl https://api.spokenalpha.com/v1/companies/IVFFAQ
Frequently asked about IVF
Where can I find INVO Fertility, Inc.'s (IVF) earnings call transcripts?
Spoken Alpha indexes IVF's earnings call transcripts at https://spokenalpha.com/companies/IVF. Each call links to attributed speakers and parsed analyst Q&A. INVO Fertility, Inc.'s own investor relations page is at https://invofertility.com/investors/.
When was INVO Fertility, Inc.'s most recent earnings call?
INVO Fertility, Inc. (IVF) held its most recent earnings call on 2023-08-14, covering fiscal Q2 2023.
What sector is IVF in?
INVO Fertility, Inc. (IVF) operates in the Healthcare sector (Medical Devices industry).